Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$403M |
| 2 |
Pinduoduo
PDD
|
+$388M |
| 3 |
ODDITY Tech
ODD
|
+$235M |
| 4 |
Sea Limited
SE
|
+$212M |
| 5 |
Comfort Systems
FIX
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$806M |
| 2 |
Illumina
ILMN
|
+$592M |
| 3 |
Mercado Libre
MELI
|
+$455M |
| 4 |
Tesla
TSLA
|
+$229M |
| 5 |
MarketAxess Holdings
MKTX
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.6% |
| 2 | Technology | 24.53% |
| 3 | Healthcare | 16.35% |
| 4 | Communication Services | 12.72% |
| 5 | Financials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XYZ
226
Block Inc
XYZ
$47.5B
| $7.25M | 0.01% |
163,692
-13,618
| -8% | -$843K |
|
227
FTI Consulting
FCN
$4.18B
| $6.69M | 0.01% |
37,509
-2,814
| -7% | -$524K |
|
228
Fortive
FTV
$18.6B
| $6.55M | 0.01% |
117,217
-12,582
| -10% | -$724K |
|
229
Sutro Biopharma
STRO
$421M
| $6.48M | 0.01% |
186,765
| – | – |
|
230
EOG Resources
EOG
$70.7B
| $6.34M | 0.01% |
50,054
-3,503
| -7% | -$446K |
|
231
Health Catalyst
HCAT
$128M
| $5.74M | 0.01% |
567,136
-23,318
| -4% | -$278K |
|
232
Tandem Diabetes Care
TNDM
$1.56B
| $5.46M | 0.01% |
262,756
| – | – |
|
233
Globus Medical
GMED
$11.2B
| $5.46M | 0.01% |
109,875
+215
| +0.2% | +$12K |
|
234
Nike
NKE
$61.9B
| $5.29M | ﹤0.01% |
55,301
-3,858
| -7% | -$397K |
|
235
GitLab
GTLB
$6.58B
| $5.14M | ﹤0.01% |
113,574
+1,395
| +1% | +$66.8K |
|
|
HUYA
236
Huya Inc
HUYA
$558M
| $5.01M | ﹤0.01% |
1,765,711
| – | – |
|
237
Oscar Health
OSCR
$8.61B
| $4.58M | ﹤0.01% |
822,088
-278,938
| -25% | -$1.95M |
|
238
Freshpet
FRPT
$3.22B
| $4.06M | ﹤0.01% |
61,611
-988
| -2% | -$70.9K |
|
239
Compañía de Cervecerías Unidas
CCU
$2.21B
| $4.01M | ﹤0.01% |
318,214
-16,900
| -5% | -$257K |
|
240
LivePerson
LPSN
$32.3M
| $4.01M | ﹤0.01% |
68,701
| – | – |
|
241
Expensify
EXFY
$245M
| $3.57M | ﹤0.01% |
1,097,896
| – | – |
|
242
Inspire Medical Systems
INSP
$1.74B
| $3.51M | ﹤0.01% |
17,704
+9,875
| +126% | +$2.49M |
|
243
Relay Therapeutics
RLAY
$4.33B
| $3.32M | ﹤0.01% |
394,450
-16,858
| -4% | -$181K |
|
244
Golub Capital BDC
GBDC
$3.42B
| $2.76M | ﹤0.01% |
187,893
+65,793
| +54% | +$933K |
|
245
Sixth Street Specialty
TSLX
$1.81B
| $2.73M | ﹤0.01% |
133,630
+54,130
| +68% | +$1.08M |
|
|
AKLI
246
DELISTED
Akili Inc
AKLI
| $2.56M | ﹤0.01% |
4,665,795
| – | – |
|
247
Alector
ALEC
$199M
| $2.38M | ﹤0.01% |
367,972
-17,092
| -4% | -$111K |
|
248
HUTCHMED
HCM
$2.17B
| $2.29M | ﹤0.01% |
135,275
-7,200
| -5% | -$103K |
|
|
NCNA
249
NuCana
NCNA
$6.12M
| $2.23M | ﹤0.01% |
732
| – | – |
|
|
GOOS
250
Canada Goose Holdings
GOOS
$856M
| $2.09M | ﹤0.01% |
+142,700
| New | +$2.33M |
|
Similar funds
Baillie Gifford & Co's Q3 2023 Portfolio in Review
As of Q3 2023, Baillie Gifford & Co held 304 positions worth $110B, down 6.8% from $118B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Baillie Gifford & Co's Q3 2023 filing shows 7 new, 53 increased, 198 reduced and 15 closed positions. Its largest new stake was ODDITY Tech: 5,559,817 shares worth $158M. The largest sale was NVIDIA, an estimated $806M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 30% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- Baillie Gifford & Co's largest Q3 2023 buy was ODDITY Tech: 5,559,817 shares worth $158M.
- Baillie Gifford & Co added most to HDFC Bank in Q3 2023, an estimated $403M increase.
- Baillie Gifford & Co's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $806M.
- Baillie Gifford & Co fully exited Futu Holdings in Q3 2023, selling an estimated $44.3M.
- Baillie Gifford & Co's ten largest holdings make up 42% of its $110B portfolio in Q3 2023.
- Baillie Gifford & Co opened 7 new positions and closed 15 in Q3 2023.
- Baillie Gifford & Co's portfolio value fell 6.8% quarter-over-quarter to $110B.
Based on Baillie Gifford & Co's 13F filing for Q3 2023, filed 13 Nov 2023.